NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

CSV download of the complete patent data set.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset the Search Filters to go back to the initial display of all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NCI E-040-2019-0-AU-03 Cross Species Single Domain Antibodies Targeting Mesothelin For Treating Solid Tumors AU National Stage 2020206308 Pending
NCI E-040-2019-0-CA-04 Cross Species Single Domain Antibodies Targeting Mesothelin For Treating Solid Tumors CA National Stage 3125484 Pending
NCI E-140-2017-0-AU-03 COMPOUNDS FOR TREATING CANCER AU National Stage 2018297271 Issued
NCI E-175-2016-0-SG-14 ANTI-KRAS-G12D T CELL RECEPTORS SG DIV 10201913959W Pending
NCI E-028-2015-1-SG-16 Anti-Mutated Kras T Cell Receptors SG DIV 10201913978R Pending
NCI E-183-2017-0-CN-06 Anti-B-cell Maturation Antigen Chimeric Antigen Receptors With Human Domains CN National Stage 201880044208.X Issued
NIA E-151-2017-0-US-10 FATTY ACID DERIVATIVES AND THEIR USE US National Stage 16/622,697 11555021 Issued PDF
NCI E-265-2015-0-SG-17 T CELL RECEPTORS RECOGNIZING HLA-CW8 RESTRICTED MUTATED KRAS` SG DIV 10201913868X Pending
NCI E-183-2017-0-US-13 ANTI-B-CELL MATURATION ANTIGEN CHIMERIC ANTIGEN RECEPTORS WITH HUMAN DOMAINS US National Stage 16/626,991 Pending
NEI E-162-2016-0-JP-09 GENE THERAPY FOR RETINITIS PIGMENTOSA JP DIV 2019-235539 Issued
NCI E-085-2013-0-AU-14 Methods for Producing Enriched Populations of Tumor Reactive T Cells from Peripheral Blood AU DIV 2019284080 Issued
NCI E-080-2014-0-US-04 ZIRCONIUM-89 OXINE COMPLEX AS A CELL LABELING AGENT FOR POSITRON EMISSION TOMOGRAPHY US DIV 16/723,601 11192903 Issued PDF
NCI E-245-2016-0-US-06 Improved Near-IR Light Antibody Drug Conjugates (ADCs) US DIV 16/723,482 10874739 Issued PDF
NIDCD E-004-2019-0-PCT-01 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY PCT PCT COMB PCT/US2019/068070 Expired
NEI E-089-2011-0-US-02 CONJUGATES FOR TREATING INFLAMMATORY DISEASE AND IDENTIFICATION OF PATIENTS LIKELY TO BENEFIT FROM SUCH TREATMENT US CON 16/722,952 Abandoned
NIDCD E-004-2019-0-EP-03 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY EP National Stage 19839761.4 Pending
NIDCD E-004-2019-0-IL-04 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY IL National Stage 284099 Pending
NIDCD E-004-2019-0-CN-02 ADENO-ASSOCIATED VIRUSES AND THEIR USES FOR INNER EAR THERAPY CN National Stage 201980085229.0 Pending
NCI E-107-2017-0-EP-03 T CELLS MODIFIED TO OVEREXPRESS PHF19 EP National Stage 18737062.2 Issued
NCI E-107-2017-0-GB-07 T CELLS MODIFIED TO OVEREXPRESS PHF19 GB EP 18737062.2 Issued
NCI E-107-2017-0-FR-06 T CELLS MODIFIED TO OVEREXPRESS PHF19 FR EP 18737062.2 Issued
NCI E-107-2017-0-DE-05 T CELLS MODIFIED TO OVEREXPRESS PHF19 DE EP 18737062.2 Issued
NCATS E-074-2019-0-US-03 ANTI-FLAVIVIRUS COMPOUNDS AND METHODS OF USE US ORD 16/721,221 11096927 Issued PDF
NIAID E-061-2018-0-PCT-01 Ebola Virus Glycoprotein-Specific Monoclonal Antibodies and Uses Thereof PCT PCT COMB PCT/US2019/067423 Expired
NIAID E-061-2018-0-EP-02 Ebola Virus Glycoprotein-Specific Monoclonal Antibodies and Uses Thereof EP National Stage 19842479.8 Issued
NCATS E-074-2019-0-PCT-02 NS-1 Inhibitors For The Treatment Of Flavivirus Infections PCT PCT PCT/US2019/067535 Expired
NCATS E-115-2018-2-US-03 EMETINE COMPOUNDS AND COMBINATION THERAPY FOR TREATMENT AND PREVENTION OF FLAVIVIRUS INFECTION US CON 16/718,343 11207315 Issued PDF
NCI E-176-2014-0-AU-17 Anti-Human Papillomavirus 16 E7 T Cell Receptors AU DIV 2019283892 Issued
NIAID E-147-2015-0-US-13 BROADLY NEUTRALIZING, CROSS REACTIVE ANTIBODIES TO HIV-1 US CON 16/718,322 Pending
NHGRI E-100-2017-0-US-05 CODON-OPTIMIZED HUMAN NPC1 GENES FOR THE TREATMENT OF NIEMANN-PICK TYPE C1 DEFICIENCY AND RELATED CONDITIONS US National Stage 16/623,863 Pending
NHLBI E-165-2014-1-US-10 LENTIVIRAL VECTOR FOR TREATING HEMOGLOBIN DISORDERS US DIV 16/717,420 11813316 Issued PDF
NCI E-176-2014-0-EP-16 EXPRESSION VECTORS FOR ANTI-HUMAN PAPILLOMAVIRUS 16 E7 T CELL RECEPTORS EP DIV 19217074.4 Pending
NCI E-162-2014-0-US-08 Human Monoclonal Antibodies (mAbs) Against EphA4 As Candidate Therapeutics US CON 16/716,803 Abandoned
NCI E-156-2014-2-US-01 Triggering RNA Interference With RNA, RNA-DNA And DNA-RNA Nanoparticles US CIP 16/717,060 Abandoned
NCI E-520-2013-0-US-19 Identification And Characterization Of HLA-A24 Agonist Epitopes Of MUC1-Oncoprotein US DIV 16/715,038 11155588 Issued PDF
NCI E-172-2017-1-US-03 METHOD FOR DETERMINING LYMPHOMA TYPE US CIP 16/713,528 11646099 Issued PDF
NCI E-040-2012-0-EP-46 Chimeric Antigen Receptors Targeting B-cell Maturation Antigen EP DIV 19216091.9 Pending
NCI E-017-2017-0-KR-08 BICISTRONIC CHIMERIC ANTIGEN RECEPTORS AND THEIR USES KR National Stage 2019-7036903 Pending
NCI E-149-2015-0-US-06 METHODS OF ISOLATING T CELLS AND T CELL RECEPTORS HAVING ANTIGENIC SPECIFICITY FOR A CANCER-SPECIFIC MUTATION FROM PERIPHERAL BLOOD US DIV 16/710,287 11629334 Issued PDF
NHLBI E-134-2017-3-SG-18 ApoC-llA Mimetic Peptides That Antagonize ApoC-111 SG DIV 10201911974U Pending
NCI E-264-2011-0-US-11 DELIVERY OF PACKAGED RNA TO MAMMALIAN CELLS US DIV 16/709,147 Abandoned
CC E-109-2017-0-US-03 PROGRESSIVE AND MULTI-PATH HOLISTICALLY NESTED NETWORKS FOR SEGMENTATION US National Stage 16/620,464 11195280 Issued PDF
NCI E-127-2017-0-EP-05 COMBINATION PDL1 AND TGF-BETA BLOCKADE IN PATIENTS WITH
HPV+ MALIGNANCIES 		EP National Stage 18729515.9 Pending
NCI E-085-2013-0-JP-13 Methods of Producing Enriched Populations of Tumor Reactive T Cells from Peripheral Blood JP DIV 2019-221431 Pending
NIDDK E-022-2019-0-PCT-02 A1 ADENOSINE RECEPTOR AGONISTS AND METHODS OF USE THEREOF PCT PCT PCT/US2019/064844 Expired
NCI E-107-2017-0-US-04 T-CELLS MODIFIED TO OVEREXPRESS PHF19 US National Stage 16/619,570 11883431 Issued PDF
NCI E-175-2016-0-HK-12 ANTI-KRAS-G12D T CELL RECEPTORS HK EP 19133082.8 Issued
NCI E-495-2013-0-JP-19 Anti-Human Papillomavirus 16 E6 T Cell Receptors JP DIV 2019-219105 Issued
NIBIB E-062-2017-0-JP-06 Systems and Methods for Three-Dimensional Fluorescence Polarization Via Multiview Imaging JP National Stage 2019-566626 Issued
NHLBI E-114-2019-0-US-02 A Pre-emphasis Technique Based On The Temperature-dependent Gradient System Behavior For Trajectory Correction In MR Imaging US ORD 16/699,415 Pending